NCT01221285
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +12 more
- Locations
-
- Johns Hopkins University School of Medicine Baltimore, Maryland, United States
Clinical trial condition
Lung Diseases, Obstructive
Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.
7,959 public trials
737 recruiting studies
Lung Diseases, Obstructive trial results
NCT01380327
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +12 more
- Locations
-
- Children's Memorial Hospital Chicago, Illinois, United States
- Johns Hopkins University School of Medicine Baltimore, Maryland, United States
- Henry Ford Health System Detroit, Michigan, United States
- Cincinnati Children's Hospital Cincinnati, Ohio, United States
NCT01153724
- Conditions
- Chronic Disease, Disease Attributes, Healthy, +6 more
- Locations
-
- 1222.48.1 Boehringer Ingelheim Investigational Site Berlin, Germany
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- 205.418.01020 Boehringer Ingelheim Investigational Site Huntington Beach, California, United States
- 205.418.01002 Boehringer Ingelheim Investigational Site Mission Viejo, California, United States
- 205.418.01014 Boehringer Ingelheim Investigational Site San Diego, California, United States
- 205.418.01011 Boehringer Ingelheim Investigational Site Wheat Ridge, Colorado, United States
NCT01483625
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- 205.479.01017 Boehringer Ingelheim Investigational Site Tucson, Arizona, United States
- 205.479.01036 Boehringer Ingelheim Investigational Site Riverside, California, United States
- 205.479.01024 Boehringer Ingelheim Investigational Site San Diego, California, United States
- 205.479.01043 Boehringer Ingelheim Investigational Site DeLand, Florida, United States
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- 205.419.01058 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
- 205.419.01053 Boehringer Ingelheim Investigational Site Stockton, California, United States
- 205.419.01061 Boehringer Ingelheim Investigational Site Centennial, Colorado, United States
- 205.419.01066 Boehringer Ingelheim Investigational Site Denver, Colorado, United States
NCT00317044
- Conditions
- Asthma, Bronchial Diseases, Deglutition Disorders, +13 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Scottsdale, Arizona, United States
- Research Site Little Rock, Arkansas, United States
- Research Site Fountain Valley, California, United States
NCT00782210
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- 1222.11.1122 Boehringer Ingelheim Investigational Site Jasper, Alabama, United States
- 1222.11.1116 Boehringer Ingelheim Investigational Site Berkeley, California, United States
- 1222.11.1121 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
- 1222.11.1111 Boehringer Ingelheim Investigational Site Fort Collins, Colorado, United States
Completed
Dietary Nitrate in COPD
NCT02148289
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
Not specified
NCT00968669
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Research Site Pell City, Alabama, United States
- Research Site Los Angeles, California, United States
- Research Site Sacramento, California, United States
- Research Site San Diego, California, United States